Efficacy of the Selctive COX-2-inhibitor Parecoxib on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS).

Trial Profile

Efficacy of the Selctive COX-2-inhibitor Parecoxib on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS).

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Parecoxib (Primary)
  • Indications Complex regional pain syndromes
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top